Biopharmaceutical Portfolio Strategies: Governance and Portfolio Management

Dates in 2025 | Register Your Interest

Understand the major components of portfolio management to capitalise on strategic opportunities. – Click Here to Download the Agenda

This course is currently not scheduled however it can be delivered for your team. To register your interest, complete the form below

Register Your Interest

 

Register your interest in the course. When we schedule dates, we will be in touch.

By clicking register, you agree to our Privacy Policy

Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.

Course Overview

 

In the dynamic and highly competitive biopharmaceutical industry, effective portfolio management is crucial for maintaining a robust pipeline, mitigating risks, and ensuring long-term success. It is critical for management and business development professionals to have the skills to critically appraise their pipelines and evaluate opportunities with ease.

 

This course aims to provide biopharma professionals with the knowledge and skills needed to optimise their organisation’s R&D and commercial portfolios. By the end of the course, participants will gain a deep understanding of managing and optimising a biopharmaceutical portfolio. They will be empowered to make strategic decisions that improve pipeline health, minimise risks, take advantage of opportunities for growth, and enhance the overall visibility of their organisation’s activities, ultimately leading to a more robust and successful portfolio.

 

Learn more about how we deliver live online training.

Key Learning Objectives

 

  • To understand the fundamentals of biopharmaceutical portfolio management and governance and corporate strategy
  • Evaluate and maintain pipeline health, ensuring a balanced and sustainable portfolio
  • Identify and manage risks and portfolio interdependencies at various stages of the drug development lifecycle
  • Recognise critical inflection points that can determine the success or failure of a project
  • Explore strategic partnering and collaboration opportunities that enhance portfolio value
  • Develop strategies for bolstering the external visibility of the organisation’s activities, enhancing investor confidence, and facilitating strategic alliances.

What is Included in a Short Live Online Course?

 

  • Direct access to an expert trainer
  • Interactive and engaging sessions
  • Access to the Educo Life Sciences Training Portal
  • Unlimited access to the recordings for 2 weeks after the session

Course Dates

 

Find out when this course is running so you can plan your training. Scroll down to view the full agenda.

2025 Dates TBC

2-Day Live Online Training
Register at the top of the page.

Group Discount

 

If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.

 

For a quote, complete our contact form by following the link. Get in touch.

Customised Team Training

 

We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.

 

For more information, complete our contact form by following the link. Get in touch.

Full Course Information and Pricing

 

  • To attend the full course, you must register online at the top of the page by selecting the course dates from the drop-down and clicking enrol to add the course to your basket. Once added, please follow the checkout instructions to pay via credit card or bank transfer.
  • There are price tiers for this course. The dates of these are located above. The earlier you register the more you save.
  • The full training course is delivered either online or in a classroom. Please check which course format you have booked.
  • For hybrid training – In the event we do not have enough people on one of the options we will contact you to discuss switching.
  • For live online courses – The dates and times of modules/sessions are subject to change.
  • For live online courses – The module/session durations are approximate.

 

Frequently Asked Questions (FAQs)

Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)

Course Information

Course Information

  • The course begins at the time stated at the top of the page
  • The course is broken up into modules outlined below
  • There will be breaks between modules
Day 1

Introduction to Portfolio Management in Biopharma

  • Overview of portfolio management principles
  • The role of governance in strategic decision-making
  • Aligning portfolio strategy with organisational goals

Pipeline Health and Management

  • Assessing pipeline diversity and balance
  • Techniques for prioritising projects and resources
  • Metrics and tools for monitoring pipeline health

Risk Management in Portfolio Governance

  • Identifying and quantifying risks at different portfolio stages
  • Implementing risk mitigation strategies
  • Decision-making frameworks for uncertain environments

Identifying and Managing Inflection Points

  • Recognising key inflection points in the development lifecycle
  • Strategic responses to clinical, regulatory, and market-driven inflection points
  • Case studies on successful and unsuccessful management of inflection points
Day 2

Strategic Partnering and Collaborations

  • Evaluating the benefits of partnerships and collaborations
  • Criteria for selecting and managing external partners
  • Leveraging partnerships to fill portfolio gaps and accelerate development

Leveraging Differentiation and Competitive Intelligence

  • Tools in competitive intelligence monitoring and interpretation. What’s your edge?

Enhancing External Visibility

  • Strategies to effectively communicate portfolio progress to external stakeholders
  • Building investor confidence through transparency and strategic messaging
  • Tools for enhancing visibility in scientific, regulatory, and commercial communities

Case Studies and Best Practices

  • Real-world examples of successful portfolio management
  • Lessons learned from high-impact partnerships and collaborations
  • Industry trends and future directions in biopharmaceutical portfolio management

Gareth is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).

 

In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.

 

Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.

This course is designed for biopharmaceutical professionals working in small biotech and large biopharma companies, specialising in portfolio management, project management, R&D strategy, governance, business development, and strategic partnerships.

 

It is also beneficial for senior executives who want to improve their understanding of portfolio governance and strategic decision-making.

Register Early To Save

 

Enrol before 18 October to save 20% (November Course)

Discount has been applied to the price above. VAT, if applicable, will be added.

Download the Agenda

 

You can view the agenda below or if you would like to receive a pdf version with all the course information, please complete the form below.

By clicking submit, you agree to our Privacy Policy

Reviews

There are no reviews yet.

Be the first to review “

Biopharmaceutical Portfolio Strategies: Governance and Portfolio Management

Dates in 2025 | Register Your Interest

Your email address will not be published. Required fields are marked *